Newman NB - Search Results

1

Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.

Graziano SL, Tatum AH, Gonchoroff NJ, Newman NB, Kohman LJ. Graziano SL, et al. Among authors: newman nb. Clin Cancer Res. 1997 Jan;3(1):87-93. Clin Cancer Res. 1997. PMID: 9815542

2

The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer.

Gajra A, Tatum AH, Newman N, Gamble GP, Lichtenstein S, Rooney MT, Graziano SL. Gajra A, et al. Lung Cancer. 2002 May;36(2):159-65. doi: 10.1016/s0169-5002(01)00463-9. Lung Cancer. 2002. PMID: 11955650

3

Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.

Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Gajra A, et al. J Clin Oncol. 2003 Mar 15;21(6):1029-34. doi: 10.1200/JCO.2003.07.010. J Clin Oncol. 2003. PMID: 12637467

4

Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease.

Gajra A, Newman N, Gamble GP, Abraham NZ, Kohman LJ, Graziano SL. Gajra A, et al. Lung Cancer. 2003 Oct;42(1):51-7. doi: 10.1016/s0169-5002(03)00285-x. Lung Cancer. 2003. PMID: 14512187

5

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.

Graziano SL, Mazid R, Newman N, Tatum A, Oler A, Mortimer JA, Gullo JJ, DiFino SM, Scalzo AJ. Graziano SL, et al. J Clin Oncol. 1989 Oct;7(10):1398-406. doi: 10.1200/JCO.1989.7.10.1398. J Clin Oncol. 1989. PMID: 2550590

6

Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.

Gajra A, Mehdi SA, Kirshner J, Newman N, Graziano SL. Gajra A, et al. Lung Cancer. 2001 May;32(2):189-96. doi: 10.1016/s0169-5002(00)00213-0. Lung Cancer. 2001. PMID: 11325490 Clinical Trial.

7

Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer.

Graziano SL, Gamble GP, Newman NB, Abbott LZ, Rooney M, Mookherjee S, Lamb ML, Kohman LJ, Poiesz BJ. Graziano SL, et al. Among authors: newman nb. J Clin Oncol. 1999 Feb;17(2):668-75. doi: 10.1200/JCO.1999.17.2.668. J Clin Oncol. 1999. PMID: 10080613

8

Prognostic markers in resected stage I and II non small-cell lung cancer: an analysis of 260 patients with 5 year follow-up.

Mehdi SA, Tatum AH, Newman NB, Gamble GP, Etzell JE, Weidner N, Kern JA, Sorscher SM, Kohman LJ, Graziano SL. Mehdi SA, et al. Among authors: newman nb. Clin Lung Cancer. 1999 Aug;1(1):59-67; discussion 68-9. doi: 10.3816/clc.1999.n.004. Clin Lung Cancer. 1999. PMID: 14725752

9

The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.

Graziano SL, Tatum AH, Newman NB, Oler A, Kohman LJ, Veit LJ, Gamble GP, Coleman MJ, Barmada S, O'Lear S. Graziano SL, et al. Among authors: newman nb. Cancer Res. 1994 Jun 1;54(11):2908-13. Cancer Res. 1994. PMID: 8187076

10

Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer.

Mehdi SA, Etzell JE, Newman NB, Weidner N, Kohman LJ, Graziano SL. Mehdi SA, et al. Among authors: newman nb. Lung Cancer. 1998 May;20(2):99-108. doi: 10.1016/s0169-5002(98)00027-0. Lung Cancer. 1998. PMID: 9711528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters